J Trojan

Summary

Publications

  1. pmc Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours
    Jerzy Trojan
    INSERM U542 and U602, Paul Brousse Hospital, Paris XI University, 16 Avenue PV Couturier, 94807 Villejuif, France
    Chemother Res Pract 2012:721873. 2012
  2. ncbi request reprint Insulin-like growth factor type I biology and targeting in malignant gliomas
    J Trojan
    INSERM U602, Paul Brousse Hospital and University Paris XI, 94807 Villejuif, France
    Neuroscience 145:795-811. 2007

Detail Information

Publications2

  1. pmc Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours
    Jerzy Trojan
    INSERM U542 and U602, Paul Brousse Hospital, Paris XI University, 16 Avenue PV Couturier, 94807 Villejuif, France
    Chemother Res Pract 2012:721873. 2012
    ..The obtained results have permitted to specify the common criteria for "anti-IGF-I" strategy: characteristics sine qua non of injected "vaccines" (cloned cells IGF-I(-) and MHC-I(+)) and of PBL cells (CD8(+) increased level)...
  2. ncbi request reprint Insulin-like growth factor type I biology and targeting in malignant gliomas
    J Trojan
    INSERM U602, Paul Brousse Hospital and University Paris XI, 94807 Villejuif, France
    Neuroscience 145:795-811. 2007
    ..The inhibition of signal transduction pathways common to growth factors and glycogenesis appears as a parallel challenge to glioblastoma multiforme inhibition studies...